5TH IPC SYMPOSIUM Advances in transplant and cellular immunotherapy
Organizers: Prof Didier Blaise, Paoli-Calmettes Institute, Marseille & Prof Mohamad Mohty, Saint-Antoine Hospital, Paris, France
This event is endorsed by:
www.marseille-symposium.com
NOVEMBER
15 -172019PALAIS DU PHARO
MARSEILLEFRANCE
FINAL PROGRAM 5TH IPC SYMPOSIUM Advances in transplant
and cellular immunotherapy
FRIDAY, NOVEMBER 15, 2019
08.00 ACUTE LEUKEMIA 16.00 WORKING PARTY
16.00 SESSION 1 – IMMUNOLOGY Chairs: A-S. Chrétien, Marseille, France,
L. Luznik, Baltimore, USA & J. Sanz, Valencia, Spain
16.00 Gamma-delta T cells D. Olive, Marseille, France
16.30 T-reg cells S. Parmar, Houston, USA
17.00 Microbiote as tool of immunomodulation F. Malard, Paris, France
17.30 Extracellular vesicles as biomarkers acute graft-versus-host disease after haplo-identical allografting with post-transplant cyclophosphamide G. Lia, Turin, Italy
18.00 Coffee break & exhibition visit
Chairs: K. Liu, Beijing, China & J. Versluis, Rotterdam, The Netherlands
18.15 Antitumor vaccination: still a topic? How? E. Fuchs, Baltimore, USA
18.45 HLA on leukemic cells after transplant L. Vago, Milano, Italy
19.15 Discussion 19.30 End of sessions
FAC
ULT
IES
Borje Andersson, Houston, USA
Jacques-Olivier Bay, Clermont-Ferrand, France
Ali Bazarbachi, Beirut, Lebanon
Didier Blaise, Marseille, France
Stefania Bramanti, Milan, Italy
Eolia Brissot, Paris, France
Luca Castagna, Milan, Italy
Christian Chabannon, Marseille, France
Anne-Sophie Chrétien, Marseille, France
Patrice Chevallier, Nantes, France
Raynier Devillier, Marseille, France
Rémy Dulery, Paris, France
Jean El Cheikh, Beirut, Lebanon
Martin Ferrando, Montevideo, Uruguay
Ephraim Fuchs, Baltimore, USA
Sabine Fürst, Marseille, France
Raùl Gabus, Montevideo, Uruguay
Jordan Gauthier, Seattle, USA
Norbert-Claude Gorin, Paris, France
Ivana Gojo, Baltimore, USA
Kazimierz Halaburda, Warsaw, Poland Samia Harbi, Marseille, France
Thomas Heinicke, Magdeburg, Germany
Jiong Hu, Shanghai, China
Xiao Jun Huang, Beijing, China
Surapol Issaragrisil, Bangkok, Thailand
Guiseppe Lia, Turin, Italy
Kaiyan Liu, Beijing, China
Francesca Lorentino, Milan, Italy Leo Luznik, Baltimore, USA
Florent Malard, Paris, France
Mohamad Mohty, Paris, France
Razan Mohty, Beirut, Lebanon
Arnon Nagler, Tel Hashomer, Israel
Daniel Olive, Marseille, France
Simrit Parmar, Houston, USA
Zinaida Peric, Zagreb, Croatia
Finn Petersen, Boise, USA
Jaime Sanz, Valencia, Spain
Álvaro Urbano-Ispizua, Barcelona, Spain
Luca Vago, Milan, Italy
Alberto Vazquez, Montevideo, Uruguay
Jurjen Versluis, Rotterdam, The Netherlands Ling Wang, Shanghai, China Ibrahim Yakoub-Agha, Lille, France
Hu Yongxian, Hangzhou, China
FINAL PROGRAM
15.45 SESSION 5 – CAR T-CELLS (1) Chairs: R. Gabus, Montevideo, Uruguay
& F. Malard, Paris, France
15.45 Present status of Car T-cells in Europe C. Chabannon, Marseille, France
16.15 Car T-cells complications I. Yakoub-Agha, Lille, France
16.45 Coffee break & exhibition visit
17.15 SESSION 6 – CAR T CELLS (2) Chairs: S. Fürst, Marseille, France,
J. Gauthier, Seattle, USA & H. Yongxian, Hangzhou, China
17.15 Car T-cells for multiple myeloma M. Mohty, Paris, France
17.45 Car T-cells: the Barcelona experience A. Urbano-Ispizua, Barcelona, Spain
18.15 Can cellular immunotherapy be brought to patientsliving far from academic medical centers? F. Petersen, Boise, USA
18.45 Discussion 19.00 End of sessions
20.30 Congress dinner
08.30 Welcome address
09.00 SESSION 2 – MYELOID MALIGNANCIES Chairs: N-C. Gorin, Paris, France,
A. Vazquez, Montevideo, Uruguay & L. Wang, Shanghai, China
09.00 The place of Haplo-HSCT in myeloid malignancies in Europe A. Nagler, Tel Hashomer, Israel
09.30 Haplo HSCT for AML R. Devillier, Marseille, France
10.00 Acute leukemia relapse after Allo-HSCT: new insights in prevention and treatment I. Gojo, Baltimore, USA
10.30 Haplo-HSCT for MDS D. Blaise, Marseille, France
11.00 Coffee break & exhibition visit
11.30 SESSION 3 – ALL Chairs: J. El Cheikh, Beirut, Lebanon
& T. Heinicke, Magdeburg, Germany
11.30 R/R ALL best approach? Monoclonal antibodies E. Brissot, Paris, France
12.00 R/R ALL best approach? Car T-cells J. Gauthier, Seattle, USA
12.30 Lunch & exhibition visit
14.00 SESSION 4 – UPDATE ON TRANSPLANT Chairs: J-O. Bay, Clermont-Ferrand, France,
S. Isaragrissil, Bangkok, Thailand & M. Ferrando, Montevideo, Uruguay
14.00 Recent updates in Beijing Haplo-HSCT protocol X. J. Huang, Beijing, China
14.30 Post-transplant cyclosphosphamide: GVL without GVHD? L. Luznik, Baltimore, USA
15.00 Sequential targeted myeloablation for myeloid malignancies B. Andersson, Houston, USA
15.30 Discussion
SATURDAY, NOVEMBER 16, 2019
5TH IPC SYMPOSIUM Advances in transplant
and cellular immunotherapy
FINAL PROGRAM 5TH IPC SYMPOSIUM Advances in transplant
and cellular immunotherapy
08.30 SESSION 7 – MICRO-TRANSPLANT Chairs: N-C. Gorin, Paris, France
& K. Liu, Beijing, China
08.30 Importance of donor source for microtransplant J. Hu, Shanghai, China
09.00 SPONSORED LECTURES Chairs: S. Bramanti, Milan, Italy
& S. Isaragrissil, Bangkok, Thailand
09.00 Advances in viral infection after Allo-HSCT D. Blaise, Marseille, France
09.30 Advances in liver toxicity after Allo-HSCT M. Mohty, Paris, France
10.00 Coffee break & exhibition visit
10.15 SESSION 8 – LYMPHOMA Chairs: J. El Cheikh, Beirut, Lebanon,
R. Gabus, Montevideo, Uruguay & Z. Peric, Zagreb, Croatia
10.15 Dose intensity in conditioning of Haplo-HSCT P. Chevallier, Nantes, France
10.45 Advanced lymphoma: best strategy? HSCT? Car T-cells A. Bazarbachi, Beirut, Lebanon
11.15 Advances in immunotherapy for Hodgkin lymphoma: monoclonal antibodies and Haplo-HSCT L. Castagna, Marseille, France
11.45 Discussion
12.00 SESSION 9 – PRACTICAL CONSIDERATIONS Chairs: K. Halaburda, Warsaw, Poland
F. Lorentino, Milan, Italy & R. Mohty, Beirut, Lebanon
12.00 Cardio toxicities in Haplo-HSCT R. Dulery, Paris, France
12.15 Sickle cell anemia: transplant and gene therapy S. Fürst, Marseille, France
12.30 HSCT in patients older than 70 years S. Harbi, Marseille, France
12.45 Summing-up
SUNDAY, NOVEMBER 17, 2019
ACKNOWLEDGMENTS
PLATINUM SPONSORS
GOLD SPONSORS
SILVER SPONSORS
SPONSORS